ストックスクリーナーアプリを入手
9.71
4.24%
-0.43
Biohaven Ltd (BHVN) 最新ニュース
Biohaven Expands At-The-Market Equity Offering Program - TipRanks
Biohaven (NYSE: BHVN) adds $350.0 million at-the-market share program - Stock Titan
Biohaven Ltd. (BHVN) upgraded to buy: Here's why - MSN
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's Why - Yahoo Finance Australia
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target - TipRanks
RBC Capital Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
Biohaven Ltd. Q1 2026 Financial Report: Key Highlights, Financial Statements, and Business Overview - Minichart
RBC Cuts Price Target on Biohaven to $22 From $23, Keeps Outperform, Speculative Risk - marketscreener.com
MSN Money - MSN
BofA Securities Maintains Biohaven(BHVN.US) With Hold Rating, Cuts Target Price to $12 - Moomoo
Biohaven Price Target Trimmed to $12 as Analyst Maintains Hold Amid Balanced Pipeline Upside and Financing Risks - TipRanks
Biohaven (BHVN) Is Up 5.7% After Narrower Q1 Loss And Pivotal Trial Plans – Has The Bull Case Changed? - simplywall.st
Biohaven Shareholders Back Board, Auditor and Executive Pay - TipRanks
Biohaven files for offering of up to $350 million common sharesSEC filing - marketscreener.com
Biohaven Ltd. (NYSE: BHVN) expands ATM program to $350M for common shares - Stock Titan
Biohaven (NYSE: BHVN) trims Q1 2026 loss and raises $178.9M - Stock Titan
Biohaven Pharma (BHVN) files mixed shelf - StreetInsider
Biohaven Ltd files for mixed shelf offering size not disclosedSEC filing - marketscreener.com
Biohaven Ltd. (NYSE: BHVN) files shelf to register shares, debt and warrants - Stock Titan
Earnings Flash (BHVN) Biohaven Ltd. Posts Q1 Adjusted Loss $0.69 per Share, Vs. FactSet Est of $-0.83 - Moomoo
Biohaven Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Biohaven (NYSE: BHVN) cuts Q1 2026 loss while funding late-stage drug pipeline - Stock Titan
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results - ChartMill
Biohaven (NYSE: BHVN) shareholders back directors, auditors and pay plan - Stock Titan
Assessing Biohaven (BHVN) Valuation After Prolonged Share Price Weakness And Elevated P/B Ratio - simplywall.st
Biohaven Faces Catalyst-Rich 2H 2026 With Multiple Key Readouts Ahead - RTTNews
BHVN SEC FilingsBiohaven 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Biohaven (NYSE: BHVN) receives 68,693 stock options award - Stock Titan
Director Julia P. Gregory awarded 68,693 Biohaven (BHVN) stock options - Stock Titan
(BHVN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
BTIG Reiterates Biohaven (BHVN) Buy Recommendation - MSN
Biohaven (NYSE:BHVN) Trading Up 5.2%Here's What Happened - MarketBeat
BHVN Stock Price, Quote & Chart | BIOHAVEN LTD (NYSE:BHVN) - ChartMill
Biohaven Obesity Trial Milestone Puts Focus On Taldefgrobep And Valuation Gap - simplywall.st
Biohaven (NYSE:BHVN) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
Biohaven (BHVN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Assessing Biohaven (BHVN) Valuation After Sharp One Month Rebound And Steep One Year Decline - simplywall.st
Biohaven Completes Enrollment for Obesity Drug Phase 2 Trial - HarianBasis.co
Moderate Buy Rating Seen For Biohaven Ltd. (BHVN) - Insider Monkey
Spinocerebellar Ataxias Pipeline Advances Toward - openPR.com
Biohaven (NYSE:BHVN) Shares Down 5.7%What's Next? - MarketBeat
Biohaven (BHVN) fuels confidence with encouraging azetukalner data - MSN
Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating - Insider Monkey
Responsive Playbooks and the BHVN Inflection - Stock Traders Daily
Here is why Biohaven (BHVN) is among the top healthcare stocks insiders are buying - MSN
Biohaven (NYSE:BHVN) Upgraded by Wall Street Zen to Sell Rating - MarketBeat
Why Biohaven (BHVN) Is Up 10.6% After Bullish Analyst Coverage Of Late-Stage Pipeline Prospects - Sahm
Biohaven Receives 'Moderate Buy' Rating from Analysts - National Today
Biohaven Ltd. (NYSE:BHVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026 (BHVN) - Seeking Alpha
Biohaven reports details on discovery of BHV-2100 - BioWorld News
Biohaven (BHVN) Stock: Price-to-Value (On the Radar) 2026-04-15Real Trader Insights - Xã Thanh Hà
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):